70. Which medications represent a high prevalence (>30%) of adverse reactions, drowsiness, fatigue, or sedation?
Answer: C
Mirtazapine, Trazodone, and Amitriptyline represent a high prevalence of adverse reactions such as drowsiness, fatigue, or sedation.
These medications are known for their sedative effects, with significant percentages of patients experiencing adverse reactions like drowsiness and fatigue.
A) Citalopram, Fluoxetine, Escitalopram
While these selective serotonin reuptake inhibitors (SSRIs) are effective for depression and anxiety, they are generally associated with fewer sedative side effects compared to other classes of antidepressants, hence they do not meet the criteria of high prevalence for drowsiness or sedation.
B) Duloxetine, Escitalopram, Bupropion
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) and can cause some fatigue, but Escitalopram and Bupropion are typically less sedating and do not have a high prevalence of adverse reactions related to drowsiness or sedation. Therefore, this combination does not represent the specified high prevalence.
C) Mirtazapine, Trazodone, and Amitriptyline
This combination is well-documented for causing significant drowsiness and sedation, with studies showing that more than 30% of patients report these adverse reactions. Mirtazapine and Trazodone are often prescribed specifically for their sedative properties, while Amitriptyline, a tricyclic antidepressant, is also known for its sedative effects.
D) Bupropion, Venlafaxine, Desvenlafaxine
Bupropion is known for being activating rather than sedating, and while Venlafaxine and Desvenlafaxine can cause some side effects, they do not reach the high prevalence of sedation or drowsiness associated with the correct answer. Thus, this option does not fulfill the criteria.
Conclusion
Mirtazapine, Trazodone, and Amitriptyline are the correct answer as they are prominently linked to high rates of drowsiness, fatigue, and sedation. In contrast, the other options either contain medications with lower prevalence of these adverse effects or include medications known for their stimulating properties, making them less relevant to the question.